NCT06627647 2026-03-27
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
AstraZeneca
Phase 3 Recruiting
Clinical Trials
17 trialsNCT07264816 2026-03-05
A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2 Recruiting
NCT07178795 2025-11-17
A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT05245071 2025-08-29
CARMEN-LC06
Sanofi
Phase 2 Terminated
NCT06868836 2025-06-27
A Study of JS207 (PD-1/VEGF Bispecific Antibody) in Combination With Chemotherapy in Advanced Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Recruiting
NCT06335355 2024-03-28
A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 2/3 Not yet recruiting
NCT02633189 2023-03-24
BEVERLY
National Cancer Institute, Naples
Phase 3 Unknown
NCT05394233 2022-05-27
Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03329911 2021-09-14
A Comparative Study of BAT1706 and EU AvastinĀ® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer
Bio-Thera Solutions
Phase 3 Completed
NCT04063449 2019-08-21
Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC
Third Military Medical University
Phase NA Unknown
NCT03992885 2019-06-20
Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT03671538 2018-09-17
Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin
The First Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT03169335 2018-08-24
Efficacy and Safety of QL1101 and AvastinĀ® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT03602027 2018-07-26
Phase I Study of the Combination of Anlotinib With Gefitinib
Second Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT03566576 2018-06-25
Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
Fujian Cancer Hospital
Phase NA Unknown
NCT03127319 2018-01-17
A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases
Affiliated Hospital of Hebei University
Phase 2 Unknown
NCT01057212 2015-09-07
Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Providence Health & Services
Phase 2 Terminated